• Researcher investigating stigma of prejudice
  
  Dr. Mindi D. Foster, a CIHR-funded researcher from Wilfred Laurier University, is leading the Canadian Life Experience Study - which focuses on discrimination based on gender, ethnicity and religion and its effects on health, well-being and quality of life.  The Waterloo Region Record, December 20 2004, p.C1
  
  
• Yusuf's paper named runner-up for Lancet
  
  Dr. Salim Yusuf, a CIHR-funded cardiologist and researcher at McMaster University, has had his paper regarding risk factors for heart attack named as a runner-up for scientific paper of the year by the British medical journal, Lancet.  CPW, December 17, 2004

December 23, 2004

• Tests sought to reject organ transplant rejection
  
  Dr. Bruce McManus, Scientific Director for CIHR's Institute of Circulatory and Respiratory Health (ICRH), is co-leading Better Biomarkers of Acute and Chronic Allograft Rejection, a $9.1 million study that will attempt to determine which organ transplant recipients will reject their grafts. This will ensure that only those at risk will take high doses of costly immunosuppressant drugs. The Vancouver Sun, December 7, 2004, p.A3
  
  
• Grant will help in analysis of autistic children
  
  Dr. Peter Szatmari, a CIHR-funded researcher from McMaster University, has received the largest Canadian grant ever awarded for the study of autism in children. Dr. Szatmari's study will also be the first one to post observations and results on the Internet for parents and policy-makers to read and comment on as the study progresses. Results here will lead to greater success in treatment methods of autistic children for both researchers and the community as a whole. The Hamilton Spectator, December 2, 2004, p.A10
  
  
• Drug prevents heart attack recovery
  
  A recent study by Dr. Joseph Casey, a CIHR-funded researcher for the University of Alberta, suggests that celecoxib, the active ingredient of Celebrex, prevents the body from recovering after a heart attack because it doesn't return to normal pH levels. The Regina Leader-Post, November 10, 2004, p.D10
  
  
• Understanding how the brain interprets language
  
  Using photos taken from a functional magnetic resonance imager, Dr. Ingrid Johnsrude, a CIHR-funded researcher from Queen's University, is trying to understand how the human brain interprets language. The fMRI images, which are more precise than X-rays, demonstrate where the blood goes in the brain of somebody listening to sentences on headphones - and will offer insights into how the brain works on a mix of good grammar and bad sense. The Kingston Whig-Standard, December 11, 2004, p. 1.
  

December 21, 2004

• Dr. Tony Pawson wins prestigious Horwitz Prize
  
  Dr. Tony Pawson, Senior Investigator and Director of Research at the Samuel Lunenfeld Research Institute is the co-recipient of the prestigious 2004 Louisa Gross Horwitz Prize from Columbia University.  The prize will be shared with Dr. Tony Hunter of the Salk Institute in San Diego.  Receiving the honour for their scientific contributions to the understanding of signal transduction (the transfer of information within and between cells), they have made important discoveries in understanding protein-tyrosine phosphorylation.  The process of molecular communication within and between cells that they revealed has led to the development of new drugs for halting cancer cell proliferation and has had a broad impact on many aspects of biomedical research.

December 20, 2004

• Enzyme discovery offers research hope
  
  Dr. Michael Hayden, a CIHR-funded researcher from the University of British Columbia, has discovered an enzyme, HIP14, that helps in the normal functioning of the nervous system. This discovery offers hope in the understanding of neurons and new approaches to therapy for neurodegenerative diseases such as Alzheimer's and Huntington Disease.
  
  
• CIHR's Annual Report Tabled in House of Commons

  On December 14, CIHR's Annual Report for 2003-04 was successfully tabled in the House of Commons. Please feel free to examine CIHR's academic and financial accomplishments for the past year.

December 15, 2004

• CIHR and its partners announce the December 2004 Requests for Applications

• Priority Announcements for the Spring 2005 open competitions

December 14, 2004

• CIHR-III launches call for nominations to CIHR HIV/AIDS Scientific Advisory Committee
  
  
• International Polar Year Secretariat calls for polar research proposals 
  

• New Canada-HOPE scholarship program
  
  The Canadian Institutes of Health Research (CIHR) via its collaborative CIHR/ Canada's Research-Based Pharmaceutical Companies (Rx&D) Research Program, in partnership with Aventis Pharma Inc., a member of the sanofi-aventis Group, have founded a scholarship program to further develop international collaborative efforts between researchers: Canada-HOPE Scholarship Program. 
  

December 8, 2004

• Stem cell discovery offers hope in fight against brain cancer
  
  Dr. Peter Dirks, a CIHR-funded researcher and neurosurgeon at Toronto's Hospital for Sick Children, has isolated "brain-cancer stem cells" in humans. Furthermore, his research team demonstrated in mice that tumour growth in brain cancers can be triggered by as few as 100 of these stem cells. This discovery could lead to new therapies to prevent tumour growth.

December 6, 2004

• CIHR announces Commercialization Management Grant Program for Technology Transfer and University-Industry Liaison Offices to recruit recent MBA graduates

December 1, 2004

• Bernstein appointed to the Scientific Board of the Grand Challenges in Global Health Initiative
• 2004 Pre-Budget Consultations

November 17, 2004

• Banting's ties to CIHR
  
  In a detailed article, the National Research Council analyses how Dr. Frederick Banting, Nobel Prize-winning scientist and discoverer of insulin, has deep ties to the Canadian Institutes of Health Research.
  
  
• 'Spotlight on Canada' hosted by CIHR's IGH
  
  On November 4, CIHR's Institute of Gender and Health (IGH) held its fourth roundtable breakfast called 'Spotlight on Canada: Women in Science, Technology and Trades.'

• The report on the first Strategic Training Initiative in Health Research workshop is now available

November 10, 2004

• Rémi Quirion awarded Prix du Québec
  
  On November 9, Dr. Rémi Quirion, Scientific Director of CIHR's Institute of Neurosciences, Mental Health and Addiction, was awarded the Wilder-Penfield prize, a Prix du Québec, which recognizes outstanding efforts in the field of biomedical sciences.

November 2, 2004

• The National Placebo Working Committee has submitted its Final Report on the Appropriate Use of Placebos in Clinical Trials in Canada to Health Canada and CIHR
  
  
• Ethics introduces new document that addresses allegations of non-compliance
  

November 1, 2004

• Sick Kids researchers unmask the potential of stem cells found in adult skin
  
  Researchers at The Hospital for Sick Children (Sick Kids) have shown that stem cells found in adult skin retain their embryonic capability of making many types of cells. This discovery affirms the potential that stem cells derived from this non-controversial source possess for the development of possible therapies for spinal cord injury and nervous system disorders.
  

October 28, 2004

• Dr. John Frank seconded to Public Health Agency of Canada
  
  The Canadian Institutes of Health Research (CIHR), along with the new Public Health Agency of Canada (PHAC) and the University of Toronto, are pleased to announce the part-time secondment of Dr. John Frank, founding Scientific Director of the CIHR Institute of Population and Public Health (IPPH), to the PHAC. 
  

October 27, 2004

• CIHR encourages science journalism through sponsorship
  
  From October 4-8, CIHR acted as a sponsor for the 4th World Conference of Science Journalists at Montreal's Marriott Château Champlain hotel. The conference gives science journalists the chance to meet with CIHR health researchers face-to-face and talk about the positive impact research will have on Canada's health care system.
  

October 26, 2004

• Hackett receives 2004 Jason A. Hannah Medal
  
  Dr. Paul Hackett, a CIHR-funded researcher from the University of Manitoba, has received the 2004 Jason A. Hannah Medal for an outstanding publication on the history of medicine in Canada. Dr. Hackett is a holder of the Associated Medical Services, Inc.- CIHR Senior Fellowship in the History of Aboriginal Health.

October 22, 2004

• The Canadian Light Source - North America's first synchrotron designed to include the study of human health issues
  
  The Canadian Light Source (CLS) is a source of brilliant light that scientists are using to view the micro-structure of materials. Located at the University of Saskatchewan, this new tool is being used to probe the structure of matter and analyze a host of physical, chemical, geological and biological processes, to name just a few applications.

October 15, 2004

• Canada's Top 40 Under 40 - Celebrating Our Best and Brightest Since 1995
  
  Nominations for Canada's Top 40 Under 40^TM program are solicited through a national campaign. People are invited to submit names of individuals whose achievements meet the five selection criteria for nomination: Vision and Leadership; Innovation and Achievement; Impact; Growth/Development Strategy; and Community Involvement and Contribution.

October 8, 2004

• Ancient virus affects MS sufferers
  
  Dr. Christopher Power, a CIHR-funded researcher from the University of Calgary, has discovered a clear link between a protein produced by ancient viral genes and multiple sclerosis. While this virus does not cause multiple sclerosis, high levels of the protein have been found in regions of the human brain damaged by the disease. This could lead to new therapeutic treatments. Vancouver Sun, September 27, 2004, p.A1.
  
  
• Bernstein argues that research strengthens Canada's health care system
  
  In the October 4 edition of the Hill Times, Dr. Alan Bernstein argues that scientific discovery and innovation, which is achieved through consistent funding, can act as a powerful and beneficial tool for the Canadian health care system.

October 6, 2004

• Antifreeze protein detected in fish
  
  Dr. Peter Davies, a CIHR-funded researcher from Queen's University, has uncovered a new antifreeze protein that enables flounder to withstand ice crystals. Being able to control the growth of ice crystals could have a number of biotechnological and medical applications.

• Health leaders from across the country meet to set new vision
  
  On September 29 and 30, Dr. Alan Bernstein participated in the Leaders' Forum for Health Research in Canada  in order to help address the challenges, recognize some solutions, set up some areas for action and identify priorities faced by health research leaders of Canadian agencies and organizations. The goal of the Forum is to develop a comprehensive and integrated vision for health research in Canada.
  

September 24, 2004

• Omega-3 fatty acid may protect brain from Alzheimer's disease
  
  In a recent CIHR-funded study, Dr. Frederic Calon, a researcher based at Université Laval along with colleagues at UCLA, has discovered that a diet high in the Omega 3 fatty acid DHA helps protect the brain from memory loss and cell damage caused by Alzheimer's disease. Globe and Mail, September 8, 2004, p.A17.
  
  
• U of S researchers investigating new treatment for osteoporosis
  
  Dr. Philip Chilibeck, a CIHR-funded researcher from the University of Saskatchewan, is seeking 360 Saskatoon postmenopausal women in order to examine the possibility that exercise and a soy-based nutritional supplement can prevent osteoporosis.
  
  
• Butler-Jones appointed Public Health Officer
  
  CIHR welcomes the appointment of Dr. David Butler-Jones, who, on September 24, was named Canada's first Public Health Officer by Prime Minister Paul Martin. Dr. Butler-Jones is a member of CIHR's Institute Advisory Board for the Institute of Population and Public Health.
  

September 16, 2004

• New Canadian Health Services and Policy Journal: Announcement, Call for Expressions of Interest for Editorial Team, and "Name that Journal" Contest
  
  Longwoods Publishing Corporation, the Canadian Association for Health Services and Policy Research (CAHSPR), and the Institute of Health Services and Policy Research (IHSPR) of the Canadian Institutes of Health Research are extremely pleased to announce the creation of a new Canadian journal for health services and policy research, to be published quarterly by Longwoods.
  
  

September 15, 2004

• Sour gas may affect people
  
  A new study by Dr. Ken Lukowiak, a CIHR-funded researcher from the University of Calgary, has uncovered that exposure to even low-levels of hydrogen sulphide, a substance which smells like rotten eggs, may be toxic to people. The resultant effect could be reduced memory or learning problems. The Globe and Mail, August 26, 2004, p. A11.

• Diabetes discovery hopeful
  
  Simon Smukler, a CIHR-funded Ph.D. candidate at the University of Toronto, has discovered insulin-producing cells in a mouse pancreas which resemble stem cells and might exist in human beings. This discovery of potentially bottomless insulin-making cells, could spell hope for diabetics. The Saskatoon StarPhoenix, August 23, 2004, p.A1.

• Building a 21st Century Health Care System: Dr. Bernstein's Op-Ed Submission to the Globe and Mail
  
  In the September 14 edition of the Globe and Mail, Dr. Bernstein addresses how to create an innovative, cost-effective, evidence-driven 21st-century health-care system available to all Canadians.

August 30, 2004

• Landmark global study shows nine factors identify majority of heart attack risk
  
  The landmark INTERHEART study, which is being coordinated by CIHR-funded Dr. Salim Yusuf from McMaster University, suggests that a nine-factor combination of lifestyle changes including stopping smoking, eating a healthier diet and exercising could lead to an 80 per cent reduction in the risks of heart attacks, one of the leading cause of death in Canada and worldwide.

August 24, 2004

• President's Message: CIHR Task Force on Career Support

• New Members appointed to CIHR Institute Advisory Boards (IAB)

August 19, 2004

• Stem cell discovery helps in blood and vessel formation
  
  Dr. Mick Bhatia, a CIHR-funded researcher from the Robarts Research Institute, has discovered the specific precursor stem cell that gives rise not only to the important cells lining our blood vessels, but also the blood itself.
   
• Mutated gene could contribute to good cholesterol
  
  Drs. Yves Marcel, Ruth McPherson and Robert Kiss, CIHR-funded researchers from the Ottawa Heart Institute, have discovered that changes or mutations in a single gene can lead to low levels of High Density Lipoprotein (HDL), the so-called good cholesterol, in a significant number of cases. The findings, published in the August 6, 2004 edition of Science magazine, could help in the fight against heart disease.
   
• Marijuana compound may affect epileptic seizures
  
  Dr. Michael Corcoran, a CIHR-funded researcher from the University of Saskatchewan, has discovered that cannabinoid drugs may increase epileptic seizures by reducing inhibition in the brain and drastically increasing electrical activity.
   
• Linking depression to heart disease
  
  In order to understand the possible relationship between heart disease and depression, a three-year, CIHR-funded study called the Canadian Cardiac Randomized Evaluation of Anti-Depressants and Psycho-Therapy Efficacy (or CREATE) is being conducted by Dr. Margie Oakander from the Peter Lougheed Centre. The Calgary Herald, June 4, 2004, p. C1.
   
• Key to early labour problems found
  
  Dr. Stephen Lye, a CIHR-funded researcher from the Samuel Lunenfeld Research Institute, has uncovered a protein that might block the function of the progesterone receptor and prevent it from working properly. Given that progesterone keeps the uterine muscle quiet so that pregnant women don't go into labour, this discovery may halt pre-term birth. The Chronicle-Herald, June 22, 2004, p.D4
   
• Cross border breast cancer study
  
  Dr. Kevin Gorey, a CIHR-funded researcher from the University of Windsor, will study breast cancer care availability and survival rates in Canada as well as the United States. The study will look at the effects of personal resources, including income, health insurance, health care access and community resources in both countries between 1985 and 2010. The Windsor Star, June 30, 2004, p.A1.
   
• New hope for Alzheimer's patients
  
  Dr. Jack Jhamandas, from the University of Alberta, has discovered that a compound which has been shown to help humans with diabetes, could also possibly be used to destroy the toxic effects of a protein that is partially responsible for Alzheimer's disease. The Vancouver Sun, June 17, 2004, p. A8. 

August 12, 2004

• New drug compound could lower cholesterol levels
  
  Dr. Kish Wasan, a CIHR-funded University/Industry Research Chair from the University of British Columbia, has developed a new drug compound for Forbes Medi-Tech Inc. which might lower LDL-cholesterol and reduce atherosclerotic plaque formation.
   
• Making insomnia treatments more available
  
  Dr. Judith Davidson, a CIHR-funded researcher from the Cancer Research Institute, is assembling a team of volunteers to take part in a study which will try to make drug-free treatments for insomnia available for cancer patients. The Kingston Whig-Standard, July 5, 2004

August 10, 2004

• August 21-22, 2004 - CIHR's Website down for reorganization of content
  
  The Canadian Institutes of Health Research (CIHR) website will be down for reorganization of content on Saturday, August 21st and Sunday, August 22nd, 2004.  We will be back up on Monday, August 23rd, 2004.  Thank you for your patience and understanding.

August 4, 2004

• Funding Opportunities for Fellowships and Doctoral Research Awards in Partnership with the Natural Health Products Directorate of Health Canada

July 26, 2004

• CIHR joins in the international registration of randomised controlled trials
  
  Dr. Alan Bernstein, President of the Canadian Institutes of Health Research (CIHR), announced today a new randomized controlled trial (RCT) policy that will require all CIHR-funded randomised controlled trials to register with an International Standard Randomised Controlled Trial Number (ISRCTN). The goal of the policy is to help ensure clinicians, researchers, patients and the public have access to information about CIHR-funded trials.

July 21, 2004

• A date has been chosen!
  
  CIHR's  third annual A Celebration of Excellence in Canadian Health Research, an awards night which  recognizes the efforts of Canada's best and brightest health researchers, will be held on November 24 at the Fairmont Chateau Laurier in Ottawa. The master of ceremonies will be Mr. André Picard, one of Canada's leading health reporters. More information to come.

July 20, 2004

• Japan-Canada Joint Health Research Program 2005
  
• Regenerative Medicine and Nanomedicine is pleased to announce the addition of the Canadian Space Agency as a partner on the June 2004 Request for Applications

July 19, 2004

• CIHR announces important Program Changes for the 2004/05 Competition Cycle

July 16, 2004

• CHSRF and CIHR sign transfer agreement for OGC projects

July 9, 2004

• Reading announces international collaboration for indigenous peoples' health
  
  On July 6, at the National Art Gallery of Canada, Dr. Jeff Reading, Scientific Director for CIHR's Institute of Aboriginal Peoples' Health, along with the New Zealand High Commissioner to Canada and the Australian High Commissioner to Canada, announced a tripartite agreement among Canada, Australia and New Zealand that will help to support collaborative research projects between the three countries and are aimed at improving the health and well-being of indigenous people. (photo)
  

July 6, 2004

• Congratulations to 14 CIHR-funded researchers appointed to RSC! (new window) [ Help ]
  
  Dr. Alan Bernstein would like to congratulate all 14 CIHR-funded health researchers who were recently appointed Fellows of the Royal Society of Canada (RSC), including Dr. Bhagirath Singh, Scientific Director of CIHR's Institute of Infection and Immunity, and Dr. David Naylor, former member of CIHR's Governing Council. (photo)
  

July 5, 2004

• Bilingualism can boost an aging brain 
  (new window) [ Help ]
  
  Dr. Ellen Bialystok, a CIHR-funded researcher from York University, has discovered that being bilingual can help people maintain their mental edge as they age. Using a study group that included middle-aged and elderly people in Toronto, Dr. Bialystok has determined those who know multiple languages can stay focused on the day's activities, and avoid distractions. 
  
• Supplement protects healthy women 
  (new window) [ Help ]
  
  Dr. Gregor Reid, a CIHR-funded researcher, has developed a supplement called PRO UTIx, which has been shown to restore the normal urogenital bacteria that protects healthy women against bladder and vaginal infections, sexually transmitted diseases - and may reduce the risk in some women of preterm labour.
  
• Study tries to relieve pain of ulcers quickly
  
  Dr. Margaret B. Harrison, from Queen's University, and Dr. Connie Harris from E.T. Now are launching a CIHR-funded clinical trial which will compare the effectiveness and cost-efficiency of two types of bandages used to treat ulcers. The study will determine which bandage heals the ulcerated area in a better way. The Waterloo Record, June 4, 2004, p.D1.
  

June 28, 2004

• Possible breast cancer reduction through exercise (new window) [ Help ]
  
  Dr. Christine Friedenreich, a CIHR-funded researcher from the University of Calgary's Faculty of Medicine, is attempting to reduce the rates of breast cancer through a 12-month exercise program called the ALPHA (Alberta Physical Activity and Breast Cancer Prevention) Trial.
  
  
• Obese women often misdiagnosed with asthma, study shows
  
  Dr. Shawn Aaron, a CIHR-funded researcher from the Ottawa Hospital Research Institute, has discovered that obese Canadian women may be taking asthma medication for no reason. In some cases, the problem could be their weight, and nothing more. The Vancouver Sun, June 8, 2004, p.A7.
  

June 24, 2004

• The Highlights of the funding and other decisions for the March 2004 competitions are now available. The detailed lists of successful applicants will be posted as of June 25, 2004

June 16, 2004

• CIHR and its partners are pleased to announce the June 2004 Requests for Applications
  
  
• Profits and health don't mix well, study shows
  (new window) [ Help ]
  
  Dr. P.J. Devereaux, a CIHR-funded researcher from McMaster University, has discovered that costs associated with Canadian hospital care would be driven up to $45.6 billion if the country allowed investor-owned for profit hospitals.
  

June 11, 2004

• Harnessing muscle sound
  
  Dr. Tom Chau, a CIHR-funded Canada Research Chair holder from Bloorview MacMillan Children's Centre in Toronto, has managed to harness the sound of muscles in a new computerized prosthesis that interprets sounds and performs movements as desired by the patient. The Regina Leader Post, May 15, 2004, p. G3.
  
  
• Nursing home residents get the right pill
  
  Thanks to CIHR funding, Dr. Paula Rochon, from Toronto's Baycrest Centre for Geriatric Care, along with Dr. Chris Lane from University of Toronto, has determined that nursing home residents are half as likely to receive an inappropriate drug compared to community-dwelling older adults.
  
  
• Arthritis drug increases risk of heart failure, study shows
  
  In a recent study, Dr. Muhammad Mamdani, a CIHR-funded researcher from Toronto's Institute of Clinical Evaluative Sciences, has discovered that Vioxx, an anti-inflammatory drug used to treat arthritis, increases the chances of heart failure among its patients by 80 per cent as compared to the drug's arch-rival Celebrex. National Post, May 28, 2004, p.A10.
  

June 9, 2004

• Strategic Funding Opportunities - Preliminary Announcements for the June 2004 Requests for Applications

June 2, 2004

• Weaver profiled in New Scientist

  On May 8, 2004, Dr. Don Weaver, a CIHR-funded Canada Research Chair in Clinical Neuroscience from Dalhousie University, was profiled in a New Scientist article for his groundbreaking research into epilepsy. Dr. Weaver is attempting to create a drug treatment that will stop epileptic seizures from developing two years after a person suffers brain trauma. The Chronicle-Herald, May 19, 2004, p.B5.

• London scientists isolate trigger for Viking disease

  Thanks to funding by CIHR, Dr. Bing Siang Gan from the Lawson Health Research Institute in London, Ont., has discovered a molecule that may be responsible for Viking disease. Dr. Gan now wants to prevent this molecule from triggering the disease, which causes tissue in the palm of the hand to contract, and forces fingers to bend. The London Free Press, May 17, 2004, p. A3

• Treating post-traumatic stress disorder

  Dr. Gord Asmundson, from the University of Regina, has assembled a special group of Canadian and American experts who will examine all factors that predispose a person to develop post-traumatic stress disorder (PTSD). Through four studies, Dr. Asmundson hopes to develop strategies to 1) prevent PTSD from ever happening, 2) intervene early so it doesn't become a chronic problem, 3) distinguish PTSD from chronic pain and 4) create an Internet-based PTSD treatment program. The Regina Leader-Post, May 15, 2004, p.D8.

• Giving a lift to those with back injuries (new window, May 17, 2004, p. 9) [ Help ]

  Dr. Joan Stevenson, CIHR-funded researcher from Queen's University, has developed a PLAD (personal lift augmentation device) prototype to help all back injury patients return to work. The PLAD acts in parallel to back muscles and allows people to lift objects using less muscle force. This could save an estimated $260 million in North American insurance claims.

• Key to treating degenerative diseases found (new window) [ Help ]

  Dr. David Thomas and John Bergeron, both CIHR-funded researchers from McGill University, have discovered a mechanism, called UDP-glucose, which identifies when a protein is misfolded (incorrectly shaped). When a protein is misfolded, it will most often mutate and cause a series of degenerative diseases, such as Alzheimer's, Parkinson's, cystic fibrosis. The discovery could lead to the development of an innovative prevention and treatment program.

June 1, 2004

• Dr. John Bergeron awarded the McLaughlin Medal (new window) [ Help ]
  
  Dr. John J. M. Bergeron, a CIHR-funded cell biologist from McGill University, has won the 2004 McLaughlin Medal from the Royal Society of Canada for his leading discoveries in protein maturation, trafficking and function. Established in 1978 by the R. Samuel McLaughlin Foundation, the award recognizes distinguished achievement in medical science in Canada.

May 31, 2004

• Dr. Morton Beiser named to Order of Canada
  
  Dr. Morton Beiser, the National Scientific Coordinator of the Reducing Health Disparities Initiative, was recently appointed to the Order of Canada for his leading work as a specialist in the field of psychiatry and epidemiology.
  

May 28, 2004

• The Inaugural CIHR Visiting Presidency at UBC

May 19, 2004

• Trying to reject anti-rejection drugs
  
  Dr. Philip Halloran, a CIHR-funded researcher from the University of Alberta, is trying to make anti-rejection drugs unnecessary by using genetic information to better match organ donors with recipients. He will use a gene chip - a handheld computer device containing information from the human genome - to make a better match. Anti-rejection drugs have strong side-effects and weaken immunity, making patients more susceptible to infectious diseases. The Edmonton Journal, April 14, 2004, p.B4.
  

May 17, 2004

• International effort launched to understand how genes communicate
  
  Dr. Michael Rudnicki, a CIHR-funded researcher from the Ottawa Hospital Research Institute, is leading a consortium of scientists from Canada, France, Britain, Singapore, Italy and the United States in an international effort to understand how genes communicate with each other to regulate the cells of the human body. By increasing this understanding, the consortium will also better understand why those communications can go awry, causing disease. CPW, May 5, 2004.
  
• Member of Parliament pays tribute to CIHR peer review community
  
  On May 14th, Sue Barnes, MP for London West, paid tribute to CIHR's peer review community. Each year, approximately 1,000 health researchers from across Canada volunteer their time to ensure that CIHR-funded research meets internationally accepted standards of scientific excellence.
  
• CIHR's Governing Council Allocates $39 Million Increase from Budget 2004

May 13, 2004

• Dr. Rossant receives 2004 Killam Prize
  
  Dr. Janet Rossant, who is both a Senior Investigator at Toronto's Samuel Lunenfeld Research Institute and a professor at the University of Toronto, will receive one of five 2004 Killam Prizes on June 2, 2004. The $100,000 prize supports scholars of exceptional ability who are engaged in research projects of broad significance and widespread interest. Dr. Rossant will be recognized for her work in the field of health sciences. Dr Rossant is a CIHR Distinguished Investigator, a member of the advisory board for CIHR's Institute of Genetics, and previously served as Chair of CIHR's working group on stem cell research.

May 12, 2004

• Projects component of OGC transferred to CIHR
  
  Beginning with the Fall 2004 call for proposals, the projects component of the Canadian Health Services Research Foundation's Open Grants Competition will be transferred over to CIHR. This unique program will support high-quality applied health services/policy and nursing research that, in turn, benefits one of CIHR's key mandates to strengthen Canada's health care system.
  
  
• Seniors over-prescribed anti-psychotic drugs, study suggests
  
  Dr. Paula Rochon, a CIHR-funded researcher, has determined that seniors are prescribed too many anti-psychotic drugs within a short period of having been admitted to long-term care facilities. This over-prescription practice could be a measure physicians are using to calm down the anxiety levels of those residents who suffer from dementia. The Hamilton Spectator, May 4, 2004, p. A01
  
  
• Hegele first time Canadian recipient of prestigious American heart award
  
  Dr. Robert Hegele, a CIHR-funded researcher from the Robarts Research Institute at the University of Western Ontario, is the first Canadian recipient of the Jeffrey M. Hoeg Arteriosclerosis, Thrombosis and Vascular Biology Award for Basic Science and Clinical Research. Dr. Hegele, who has conducted groundbreaking research in the fields of cardiovascular disease and diabetes, received the award on May 8 by the American Heart Association. CPW, April 30, 2004
  
  
• CIHR remembers child psychiatrist Dr. "Dan" Offord
  
  Dr. David R. (Dan) Offord, a CIHR-funded researcher, an internationally respected child psychiatrist and a recipient of the Order of Canada passed away on April 10, 2004 after a long struggle with cancer. All those at CIHR, and specifically IHDCYH, wish to pass on sincere condolences to Dr. "Dan's" family and friends. The Globe and Mail, May 1, 2004, p.F10.

May 11, 2004

• CIHR President, Dr. Alan Bernstein, to spend one week at University of British Columbia - CIHR Inaugural Annual Visiting Presidency

May 5, 2004

• Dr. Tony Pawson elected foreign associate of U.S. National Academy of Sciences
  
  Dr. Tony Pawson, Director of Research at the Samuel Lunenfeld Research Institute, a CIHR Distinguished Investigator and winner of CIHR's Michael Smith prize has been elected as a foreign associate of the U.S. National Academy of Sciences for his distinguished and continuing achievements in research.
  
  "Tony is one of Canada's and the world's most distinguished health researchers.  Election to the National Academy of Sciences is deserved recognition of Tony's important contributions to our understanding of the fundamental molecular mechanisms of how normal and cancer cells behave" said Dr. Alan Bernstein, President of CIHR.

April 27, 2004

• Results of the Target Obesity Personnel Awards 2003 Competition

April 23, 2004

• A team of Finnish and CIHR-funded Canadian scientists identify genes involved in asthma
  
  Science, Vol. 304,  9 April 2004, No. 5668, pages 300-304 (article entitled "Characterization of a Common Susceptibility Locus for Asthma-Related Traits")
  
• Friends of CIHR's Annual Symposium/Forum 2004 will take place on May 6^th, 2004 at the Winnipeg Convention Centre, in conjunction with the National Research Forum for Young Investigators in Circulatory and Respiratory Health.
  

April 22, 2004

• Mutated cystic fibrosis gene corrected in mice
  
  Dr. Gergely Lukacs, a CIHR-funded researcher at Toronto's Hospital for Sick Children, has been able to correct a mutated cystic fibrosis gene in mice using a treatment made up of an extract from a spice called turmeric.

April 21, 2004

• Study findings offer diabetes breakthrough
  
  Dr. Anthony Jevnikar, a CIHR-funded scientist from the Lawson Health Research Institute, has managed to prevent mice that are prone to diabetes from developing the disease by feeding them proteins made by insulin-producing cells of the pancreas.
  The London Free Press, March 31, 2004, p.B1
  
• Therapeutic HIV vaccine set to be tested
  
  Dr. Jonathan Angel, a CIHR-funded researcher from the Ottawa Health Research Institute, is set to launch the first Canadian-led trial of a therapeutic HIV vaccine, which combines drug products in an effort to boost the immune systems of HIV sufferers.
  The Ottawa Citizen, March 31, 2004, p. B1

  April 7, 2004

• Vancouver site for NAOMI closer to reality
  
  Dr. Martin Schechter, a CIHR-funded researcher from the University of British Columbia, will shortly be recruiting 158 people for the North American Opiate Medication Initiative (NAOMI) site in Vancouver. The Vancouver site is part a Canada-wide trial to prescribe heroin to see if it helps stabilize addicts and improve their health. CP Wire, March 25, 2004 and Vancouver Sun, March 25, 2004, p. B1.

April 5, 2004

• Call for Nominations for Panel Members: The Interagency Advisory Panel on Research Ethics (PRE) - Deadline: May 7, 2004
  
• Chair of National Consultation on Access to Scientific Research Data Announced
  
  Dr. David Strong, former president of the University of Victoria, has been appointed chair of the task force responsible for overseeing the forthcoming National Consultation on Access to Scientific Research Data (NCASRD). NCASRD is a partnership initiative of the Canadian Institutes of Health Research, the National Research Council, the Canada Foundation for Innovation and the Natural Sciences and Engineering Research Council, which was created to facilitate open and long-term access to data coming from natural and medical sciences research.
  
• The Interagency Advisory Panel on Research Ethics (PRE) launches its on-line Tutorial for the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS).

March 31, 2004

• Researcher to track brain changes in Parkinson's sufferers, using MRI machines
  
  Dr. Wayne Martin, from the University of Alberta, has launched a CIHR-funded study worth approximately $725,000 that will develop techniques using MRI machines to detect abnormalities in the brains of those who suffer from Parkinson's. The Edmonton Journal, March 23 2004, p.B3

March 23, 2004

March 16, 2004

• Governing Council meets in Ottawa March 16-17, 2004
   
• In memory of Jean-François St-Denis
  
• CIHR and CMA to fund research that will shed light on physician health
  Thanks to funding from CIHR and the Canadian Medical Association, two studies will shed light into the field of physician health. One will look for a better understanding of problems such as stress and other mental harms, while the other will produce a basis for collecting common data in each Canadian province about physician health programs.

March 15, 2004

• Detecting the early warning signs for Alzheimer's disease
  
  Dr. Wilfred Jefferies, a CIHR-funded researcher from the University of British Columbia, has discovered that mice that have been genetically modified to develop Alzheimer's symptoms, exhibit noticeable gaps in their blood-brain barriers. These barriers provide a layer of protection for the brain against diseases like Alzheimer's. Dr. Jefferies will study if these gaps act as an early warning sign of the onset of the disease. The Calgary Herald, March 4, 2004, p. A8.
• Exercise helps spinal cord patients
  
  According to research by Dr. Kathleen Martin Ginis, a CIHR-funded researcher from McMaster University, spinal cord patients who received fitness training regularly not only increase their strength but also experience less pain and depression. The Hamilton Spectator, March 3, 2004, p. A07.
• New technology offers insights into DNA
  
  Using new technology, Dr. Victor Ling, CIHR Governing Council member and researcher, along with his team from the B.C. Cancer Agency, has discovered a new way of scanning DNA that will make it much easier to identify genes that cause cancer. This should allow researchers to better pinpoint genetic abnormalities and develop treatments. The Saskatoon StarPhoenix, February 17, 2004, p. B6.
• Microchip on the brain
  
  Using a snail specimen, Dr. Naweed Syed, a CIHR-funded researcher from the University of Calgary, along with European researchers, has proven that it is possible cultivate a network of brain cells that reconnect on a silicon chip. This could help in areas as diverse as the control of artificial limbs as well as impaired vision.

March 8, 2004

• Gene interactions could offer disease insights
  
  An international team of experts, led by CIHR-funded Drs. Brenda Andrews, Charles Boone, and Howard Bussey, has defined a network of interactions amongst 1,000 genes in a yeast cell. Their research may yield important new insights into how genes interact in complex human diseases, such as diabetes, schizophrenia and Alzheimer's disease.

March 5, 2004

• Robarts highlights recent grantees
  [ External PDF (66 KB) | Help ]
  
• Recruitment of IAB members: Apply online until April 7, 2004 for membership on any of CIHRs thirteen Institute Advisory Boards.

March 3, 2004

• The Canadian Institutes of Health Research announces upcoming public consultations on draft Privacy Best Practice Guidelines, beginning March 2004

February 27, 2004

• Minister Pettigrew announces CIHR Operating Grant results
  • Speech
  • Press Releases

• Submission of applications for March competition: Two-day extension for Nova Scotia, New Brunswick and Prince Edward Island applicants.
  
  Due to the recent snowstorm which affected both Nova Scotia, New Brunswick and PEI, applicants from Universities in these three Provinces will have two extra days in which to submit their applications. Applications submitted to CIHR should be courier-stamped or post-marked no later than Wednesday 3rd March.

• CIHR President believes health research & innovation central to Canada's future [ HTML | PDF (103 KB) | Help ]
  
  In the February 2, 2004 edition of the Hill Times, Dr. Alan Bernstein provided his views on the importance of health research in the 21st Century. Dr. Bernstein argues that health research is an important driver for strengthening our health care system and supporting a knowledge-based economy.
  
  
• Research study sheds new light on hospital care for cardiac patients [ Press Release ]
  
  Up to 400 lives per year could be saved if more heart attack and heart failure patients received needed medications before leaving the hospital. This is one of the many findings detailed in the Quality of Cardiac Care in Ontario report. This research was supported by the Institute for Clinical Evaluative Sciences, the Heart and Stroke Foundation of Canada and the Canadian Institutes of Health Research.

• Duchenne Muscular Dystrophy treatment has promising results
  
  The results of the first clinical trial on  three people from Quebec affected by Duchenne Muscular Dystrophy raise the possibility of a treatment for this debilitating disease. A Quebec research team, directed by Dr. Jacques-P. Tremblay of the CHUL Research Centre, part of the Centre hospitalier universitaire de Québec, has developed an experimental treatment based on the transplantation of cells called myoblasts.

• Study offers hope for MS sufferers
  
  Dr. Sam David, a CIHR-funded researcher from McGill University Health Centre, has identified an enzyme that may control the onset and progression of multiple sclerosis (MS) in mice. Dr. David's discovery represents hope for the 35,000 Canadians who suffer from MS's debilitating symptoms. The Victoria Times Colonist, February 5, 2004.
  
  
• 'Brilliant' CIHR-funded researcher passes away suddenly
  
  Dr. Bernard O'Brien, a CIHR-funded researcher from McMaster University who was commonly described as 'brilliant' for his research into the evaluation of new medical technologies and drugs, passed away suddenly on Friday, February 13. He was 44. The Hamilton Spectator, February 14, 2004, p. A08.

• Advocate of universal access to health care passes away
  
  Cecil G. Sheps, a Canadian-born medical doctor who helped to create a system of universal access to health care in Saskatchewan in the 1940s, and continued to advocate a similar program of access in the United States, has passed away at age 90.

• Discovery will lead to new treatments for Parkinson's
  
  Dr. Bin Hu, a CIHR-funded researcher from the University of Calgary, has discovered how the brain processes sensory cues in the thalamus, which ultimately prepares the body for movement. His research will help in the development of better treatments for movement disorders such as Parkinson's disease.

• Revolutionary skin-mending discovery
  
  Dr. Aziz Ghahary, a CIHR-funded researcher from the University of Alberta, has discovered that by cloning a cell-to-cell messenger, he will likely be able to develop new treatments that lessen or even prevent the disfiguring scars caused by serious burns and other major wounds. Vancouver Sun, January 2, 2004, p.A4.
  

• Information regarding the Canada Graduate Scholarships Master's Awards (CGSMA) administered by CIHR is now available

• Protein Discovery May Offer Answers for Disease
  
  Dr. Wei Xiao, a CIHR-funded researcher from the University of Saskatchewan, has discovered that the interaction of two proteins, MMS2 and UBC13, could help the human body's immune system fight off infection. It is a finding that could lead to new drug therapies for cancer, SARS and HIV.

• CIHR President Dr. Alan Bernstein launches strategic plan -- Investing in Canada's Future: CIHR's Blueprint for Health Research and Innovation
  
  Known as Blueprint 2007, the document articulates CIHR's vision, mandate and strategic direction for the coming years. The foundation of Blueprint 2007 rests on CIHR's achievements over the past three years and is a significant building block in CIHR's long-term strategy of becoming Canada's main engine of health research discovery and innovation.
  

• Channel kills brain cells, study shows [ external PDF (350 KB) | Help ]
  
  Drs. Michael Tymianski and John MacDonald, CIHR-funded researchers from Toronto Western Hospital and the University of Toronto respectively, have discovered that when strokes occur, TRPM7, a lethal channel, develops to cause brain cell death.  By interrupting the development of this channel's 'chain reaction' progression, Drs. Tymianski and MacDonald have also found a way to extend the life of brain cells.
  

• Study shows antidepressants may have an impact on breast cancer
  
  Dr. Nancy Kreiger, a CIHR-funded researcher from Cancer Care Ontario, has discovered a modest link between antidepressants and an increase in breast cancer. The Charlottetown Guardian, December 16, 2003, p. C1.
  
• Videophones revolutionize palliative care
  
  Thanks to support from CIHR, Dr. Marilynne Hebert from the University of Calgary, is using videophones as a way of delivering effective face-to-face home care among patients who are bed-ridden or unable to leave their homes. Calgary Herald, December 9, 2003, p.A1.
  

• Amino acid prevents egg shrinkage
  
  Thanks to CIHR-funding, Dr. Jay Baltz from the Ottawa Health Research Institute has discovered that an amino acid called Glycine controls the size of eggs and early embryos among mouse models. This may lead to successful in-vitro fertilization and the development of more effective infertility treatments. Vancouver Sun, November 26, 2003, p.A9.

• Electronic stimulation reawakens paralyzed limbs
  
  Dr. Milos Popovic, a CIHR-funded researcher from the Toronto Rehabilitation Institute, has discovered a method for electronically stimulating the arms and legs of patients. CTV, November 11, 2003.
  
• Ottawa Researcher Receives Lifetime Achievement Prize
  
  On December 8, 2003, Dr. Dan McIntyre, a CIHR-funded Psychologist with Carleton University's Neuroscience Institute, was awarded a $50,000 US for the Lifetime Achievement Prize from the American Epilepsy Society.  Dr. McIntyre's research could lead to a cure for Epilepsy, as well as improved treatments for mental illnesses, such as depression. The Ottawa Citizen, December 8, 2003, p.B3.